CURI BIO
Curi Bio they provides medicines by integrating human cells, systems, and datas.
CURI BIO
Industry:
Artificial Intelligence Biopharma Biotechnology Medical Service Industry
Founded:
2015-01-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.curibio.com
Total Employee:
1+
Status:
Active
Contact:
+1 (800) 913-4403
Email Addresses:
[email protected]
Total Funding:
16 M USD
Technology used in webpage:
Amazon Facebook Sharer Pinterest Amazon CloudFront Reddit
Similar Organizations
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
NGM Biopharmaceuticals
NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system.
Rainier Therapeutics
Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Sunshine Biopharma
Sunshine Biopharma focuses on the research, development, and commercialization of drugs for the treatment of various forms of cancer.
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2020-07-23 | Dana Solutions | Dana Solutions acquired by Curi Bio | N/A |
| 2019-09-25 | Silene Biotech | Silene Biotech acquired by Curi Bio | N/A |
Investors List
DS Asset Management
DS Asset Management investment in Series A - Curi Bio
Dynamk Capital
Dynamk Capital investment in Series A - Curi Bio
UTC Investment
UTC Investment investment in Series A - Curi Bio
Dynamk Capital
Dynamk Capital investment in Series A - Curi Bio
Official Site Inspections
http://www.curibio.com Semrush global rank: 5.53 M Semrush visits lastest month: 1.54 K
- Host name: 198.185.159.145
- IP address: 198.185.159.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Curi Bio"
Curi Bio
Curi Bio is a science-first organization that offers best-in-class products and technical support. Our team of experts is standing by to help you succeed. Curi Bio develops human-relevant …See details»
Company — Curi Bio
Curi Bio is a science-first organization that offers best-in-class products and technical support. Our team of experts is standing by to help you succeed.See details»
Contact — Curi Bio
Curi Bio is a science-first organization that offers best-in-class products and technical support. Our team of experts is standing by to help you succeed. Curi Bio team members are here to …See details»
Curi Bio Company Profile 2024: Valuation, Funding & Investors
Developer of biosystem platforms designed to facilitate the discovery of next-generation human medicines by integrating human cells, systems and data.See details»
Curi Bio - Crunchbase Company Profile & Funding
Curi Bio integrates human stem cells, systems, and AI-enabled data analytics for the development of new therapeutics. View contacts for Curi Bio to access new leads and connect with decision-makers.See details»
Curi Bio - LinkedIn
Through an integrated platform featuring advanced 3D tissue models of disease, biosystems enabling clinically relevant functional analyses, and AI/ML-enabled insights, Curi Bio merges...See details»
Curi Bio Awarded Over $4.4M in NIH Grants to …
Aug 23, 2023 · Curi Bio’s preclinical discovery platform combines human stem cells, systems, and data to accelerate the discovery of new medicines. The Curi Engineâ„¢ is a comprehensive, bioengineered platform...See details»
NanoSurface Biomedical Is Now Curi Bio | Business Wire
Jul 14, 2020 · To facilitate rapid growth of operational and R&D activities, including additional product and service offerings for pharma and biotech customers, Curi Bio has relocated its corporate...See details»
Curi Bio Recognized as a 2024 Deloitte Technology …
5 days ago · SEATTLE–(BUSINESS WIRE)–#BioTech–Curi Bio, a leader in delivering human functional data to drug discoverers through advanced preclinical tissue models, is proud to announce its selection as one of Deloitte’s …See details»
Curi Bio and NEXEL Announce Celogics, Joint Venture …
Oct 26, 2021 · Curi Bio’s preclinical discovery platform combines human stem cells, systems, and data to accelerate the discovery of new medicines. The Curi Engine is a seamless, bioengineered platform that...See details»
Product Catalog - Curi Bio
By integrating human iPSC-derived cells, tissue-specific biosystems, and AI-enabled data analytics, Curi Bio is developing platforms that make preclinical biological research more …See details»
Curi Bio Recognized as a 2024 Deloitte Technology Fast 500 Winner
6 days ago · Curi Bio is a science-first organization that offers best-in-class products and technical support. Our team of experts is standing by to help you succeed.See details»
Curi Bio raises $10M for stem-cell based drug discovery platforms
Dec 29, 2021 · Seattle-based startup Curi Bio has raised $10 million to advance its platforms for drug discovery, based on human stem cells. Curi Bio enables screening of new drugs using …See details»
Curi Bio - Craft
Curi Bio (formerly known as NanoSurface Biomedical) is a company that develops and commercializes integrated drug discovery platforms leveraging human iPSC-derived cells, …See details»
Curi Bio - Overview, News & Similar companies | ZoomInfo.com
Curi Bio contact info: Phone number: (800) 913-4403 Website: www.curibio.com What does Curi Bio do? Curi Bio's preclinical discovery platform combines human stem cells, systems, and …See details»
Curi Bio | COLAAB - animalmethodsbias.org
Curi Bio humanizes the drug discovery process by using tissue engineering, stem cell technology, and AI machine learning to accelerate the discovery of new medicine.See details»
Curi Bio Closes $10M Series A in Oversubscribed Round
Dec 29, 2021 · SEATTLE-- ( BUSINESS WIRE )-- Curi Bio Inc., a leading developer of human stem cell-based platforms for drug discovery, announced today the second closing of a $10 …See details»
Curie.Bio
Curie.Bio significantly improves your ability to create impactful medicines while minimizing long-term dilution. Our unparalleled team and capital-efficient model provide you with immediate …See details»
Peer-Reviewed Publications — Curi Bio
Curi Bio is a science-first organization that offers best-in-class products and technical support. Our team of experts is standing by to help you succeed. Contact UsSee details»
Distributors - Curi Bio
Curi Bio is a science-first organization that offers best-in-class products and technical support. Our team of experts is standing by to help you succeed. Contact UsSee details»